Skip to main content

Table 2 Change from baseline and difference vs. control for blood parameters, waist circumference, SBP and DBP

From: Yoga’s effect on inflammatory biomarkers and metabolic risk factors in a high risk population – a controlled trial in primary care

  Intervention group 1 Intervention group 2 Group 3
Yoga class group Yoga at home group Control group
OC PPS OC PPS OC PPS
n = 28 n = 21 n = 26 n = 20 n = 26 n = 22
Mean (CI) Mean (CI) Mean (CI) Mean (CI) Mean (CI) Mean (CI)
Cholesterol (mmol/L) change from baseline 0.3 (0.1–0.5)* 0.2 (−0.0–0.4) −0.1 (−0.3–0.2) −0.1 (−0.2–0.4) 0.0 (−0.3–0.3) 0.1 (−0.3–0.4)
Difference vs. control 0.3 (−0.1–0.6) 0.1 (−0.2–0.5) −0.1 (−0.4–0.3) −0.1 (−0.4–0.3)   
LDL (mmol/L) change from baseline 0.1 (−0.0–0.3) 0.1 (−0.1–0.3) −0.2 (−0.5–0.1) −0.1 (−0.3–0.2) 0.0 (−0.3–0.3) 0.0 (−0.3–0.3)
Difference vs. control 0.2 (−0.2–0.5) 0.1 (−0.3–0.5) −0.2 (−0.6–0.2) −0.1 (−0.5–0.4)   
HDL (mmol/L) change from baseline 0.0 (−0.1–0.1) 0.0 (−0.1–0.1) 0.0 (−0.1–0.1) 0.0 (−0.0–0.1) 0.0 (−0.1–0.1) 0.0 (−0.1–0.1)
Difference vs. control −0.0 (−0.1–0.1) −0.0 (−0.2–0.1) −0.0 (−0.1–0.1) −0.0 (−0.1–0.1)   
TGs (mmol/L) change from baseline 0.3 (0.1–0.5)* 0.3 (0.0–0.5)* 0.1 (−0.1–0.2) 0.1 (−0.1–0.2) −0.3 (−0.8–0.1) −0.3 (−0.8–0.2)
Difference vs. control 0.6 (0.1–1.1)* 0.6 (0.0–1.1)* 0.4 (−0.1–0.8) 0.4 (−0.1–0.9)   
FP-glucose (mmol/L) change from baseline 0.1 (−0.2–0.4) 0.0 (−0.3–0.3) −0.1 (−0.3–0.2) −0.1 (−0.4–0.2) −0.4 (−1.1–0.3) −0.4 (−1.2–0.4)
Difference vs. control 0.5 (−0.2–1.3) 0.4 (−0.5–1.3) 0.4 (−0.4–1.1) 0.3 (−0.6–1.2)   
HbA1c (mmol/mol) change from baseline −1.4 (−3.9–1.2) −1.9 (−4.9–1.1) −0.2 (−1.5–1.1) 0.3 (−1.3–1.9) −0.8 (−2.0–0.3) −0.9 (−2.2–0.4)
Difference vs. control −0.5 (−3.3–2.3) −1.0 (−4.0–2.0) 0.6 (−1.1–2.3) 1.2 (−0.7–3.2)   
hs-CRP (mg/L) change from baseline −0.8 (−2.2–0.5) −0.6 (−2.3–1.1) 0.2 (−0.6–1.0) 0.1 (−1.0–1.2) 0.4 (−1.2–2.1) 0.5 (−1.4–2.4)
Difference vs. control −1.2 (−3.3–0.8) −1.1 (−3.6–1.3) −0.2 (−2.0–1.6) −0.4 (−2.7–1.8)   
IL-6 (pg/mL) change from baseline −0.8 (−2.3–0.7) −0.8 (−2.4–0.9) 1.1 (−0.2–2.4) 1.1 (−0.4–2.5) 1.0 (−0.8–2.8) 1.2 (−0.7–3.1)
Difference vs. control −1.8 (−4.1–0.5) −2.0 (−4.5–0.5) 0.2 (−1.9–2.3) −0.1 (−2.5–2.2)   
Waist circumf. (cm) change from baseline −0.4 (−1.9–1.1) −0.1 (−1.9–1.6) 0.6 (−1.5–2.7) 0.8 (−1.9–3.5) −0.0 (−2.3–2.3) 0.1 (−2.4–2.6)
Difference vs. control −0.4 (−3.1–2.2) −0.2 (−3.2–2.8) 0.6 (−2.4–3.7) 0.7 (−2.8–4.3)   
SBP (mmHg)a change from baseline 0.3 (−5.8–6.4) −0.2 (−8.1–7.8) −6.8 (−11.6–2.11)* −6.1 (−11.7–0.7) −2.3 (−7.6–3.0) −1.9 (−7.7–4.1)
Difference vs. control 2.6 (−5.4–10.5) 1.7 (−7.9–11.1) −4.4 (−11.5–2.4) −4.2 (−12.3–3.5)   
DBP (mmHg)a change from baseline 0.2 (−3.2–3.7) 0.3 (−3.9–4.3) −4.4 (−7.3–1.3)* −3.9 (−7.3–0.1) 0.8 (−3.2–4.4) 1.0 (−3.2–4.9)
Difference vs. control −0.6 (−5.3–4.6) −0.8 (−6.2–5.0) −5.2 (−9.6–0.2)* −4.9 (−9.9–0.1)*   
  1. *p < 0.05 vs. control group
  2. apreviously published results [3]
  3. CI Confidence interval, DBP Diastolic blood pressure, HDL High-density lipoprotein, hs-CRP High-sensitivity C-reactive protein, LDL Low-density lipoprotein, OC Observed cases, PPS Per-protocol set, SBP Systolic blood pressure, SE Standard error of the mean, TGs Triglycerides
  4. The PPS consists of all patients who practiced yoga at least once a week for 9 weeks or more and who had no change in medication during the study period